Telmisartan: Indications, Dosing, and Contraindications
Indications
Telmisartan is indicated for the treatment of hypertension to lower blood pressure (reducing fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions) and for cardiovascular risk reduction in patients unable to take ACE inhibitors. 1
- Hypertension management: Telmisartan is a first-line angiotensin II receptor blocker (ARB) recommended for initial treatment of confirmed hypertension (BP ≥140/90 mmHg), preferably in combination with a dihydropyridine calcium channel blocker or thiazide/thiazide-like diuretic 2
- Cardiovascular risk reduction: Specifically indicated for patients who cannot tolerate ACE inhibitors 1
- Metabolic benefits: Beyond blood pressure control, telmisartan demonstrates favorable effects on insulin resistance, lipid levels, left ventricular hypertrophy, and renal function due to its partial PPARγ-agonistic properties 3, 4
Dosing
For hypertension, start telmisartan at 40 mg once daily and titrate to a dose range of 40-80 mg once daily; for cardiovascular risk reduction, use 80 mg once daily. 1
Hypertension Dosing:
- Starting dose: 40 mg once daily 2, 1
- Dose range: 40-80 mg once daily 2, 1
- Alternative starting dose: 20 mg once daily may be used in specific populations (though 40 mg is standard) 2
- Maximum effective dose: 80 mg once daily provides optimal blood pressure reduction 5, 6
Cardiovascular Risk Reduction:
- Fixed dose: 80 mg once daily 1
- Blood pressure monitoring is recommended, with adjustment of other antihypertensive medications as needed 1
Administration Details:
- Timing: May be taken with or without food 1
- Frequency: Once daily dosing provides 24-hour blood pressure control due to telmisartan's long elimination half-life 3, 6
- Combination therapy: When used with other antihypertensives, fixed-dose single-pill combinations are preferred to improve adherence 2
Dose-Response Evidence:
- Doses of 40-80 mg produce mean reductions in systolic blood pressure of 15.5-17.9 mmHg and diastolic blood pressure of 10.5 mmHg 7, 5
- Telmisartan 80 mg demonstrates superior efficacy compared to losartan 50 mg or valsartan 80 mg, particularly during the last 6 hours of the dosing interval 7
Contraindications
Telmisartan is absolutely contraindicated in patients with known hypersensitivity (including anaphylaxis or angioedema) to telmisartan or any component, and must not be co-administered with aliskiren in diabetic patients. 1
Absolute Contraindications:
- Hypersensitivity reactions: Known anaphylaxis or angioedema to telmisartan or any product component 1
- Aliskiren co-administration in diabetes: Do not combine with aliskiren (a direct renin inhibitor) in diabetic patients 1
- Pregnancy: Discontinue immediately when pregnancy is detected due to fetal toxicity risk (drugs acting on the renin-angiotensin system cause injury and death to the developing fetus) 1
Relative Contraindications and Precautions:
- Dual RAS blockade: Do not combine with ACE inhibitors (increased risk of hypotension, hyperkalemia, and renal impairment) 2
- Volume/salt depletion: Correct before initiating therapy to avoid symptomatic hypotension 1
- Bilateral renal artery stenosis: Risk of acute renal failure 2
- Severe renal impairment: Use with caution; monitor renal function carefully 1
- Hepatic impairment: Monitor carefully in patients with impaired hepatic function 1
- Hyperkalemia risk: Increased risk in patients with chronic kidney disease or those on potassium supplements or potassium-sparing drugs 2
- Lactation: Do not breastfeed during treatment 1
History of Angioedema:
- Patients with a history of angioedema with an ACE inhibitor can receive an ARB beginning 6 weeks after the ACE inhibitor is discontinued 2
- Do not use if patient has history of angioedema with ARBs 2